Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-03-25

FDA Approved: YERVOY — Original Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA approved YERVOY (ipilimumab) under the original application from E.R. Squibb & Sons for the treatment of malignant melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yervoy (ipilimumab)

Snippet

ORIG AP for YERVOY (IPILIMUMAB)